Canadian CANNAINVESTOR Magazine August / September 2017 - Page 207


- Increased revenue by 26% from $992,682 to $1,252,297, driven by growth in sales of the Company's flagship LivRelief products.

- Completed a licensing agreement with Dosecann Inc. and ARA-Avanti RX Analytics to develop a unique suite of standardized cannabis-based products for medical cannabis research, development, and commercialization markets.

- Advanced product development for the Company's pharmaceutical portfolio.

- Expanded the Company's patent portfolio to 8 pending patents highlighting the broad applicability of the Company's proprietary delivery system.

- Increased operating efficiencies and reduced the number of employees, resulting in annual savings of approximately $750,000, while achieving record revenues for a quarter.

- Completed a licensing agreement with Canopy Growth Corporation (TSX: CGC) for the transdermal delivery of medical cannabis.

- Subsequent to December the Company announced its successful pre-clinical work with the natural ingredient berberine for the prevention and treatment of cardiovascular disease related to high cholesterol and triglyceride levels.

- Delivra Signs Technology Licensing Agreement with Kalytera Therapeutics.

The relatively low market cap combined with increasing revenues and what appears to be a series of news releases suggesting Delivra intends to have more than just a footnote presence in this industry may suggest this company is worth further due diligence.


A market cap of approximately $12M and an estimated annualized revenue of $5.3M (per their most recent SEDAR filing). As always, one needs to look at the Financials and news releases and coverage to see if the current share price and market capitalisation are justified. A year over year reduction in sales does stand out; however, significant subsequent monthly sales data somewhat mitigates. Recent highlights:

- Included on the CannaInivestor Magazine Top Stock List Pick.

- Industrial Hemp Facility Expansion underway. SOURCE

- The company is readying for upwards of $100M in sales (per their website).